impower 010: adjuvant atezolizumab in nsclc - onctalk lung 2023
Published 8 months ago • 91 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
14:00
asco 2021 lung recap: impower010: atezolizumab after chemo in non-small cell lung cancer
-
1:57
keynote 091: adjuvant pembrolizumab - onctalk lung 2023
-
2:23
q&a: what does monitoring look like after adjuvant chemotherapy? - onctalk lung 2023
-
1:44
extended interval dosing for pembrolizumab - lung cancer onctalk 2022
-
9:24
impower010 supports adjuvant atezolizumab in early-stage nsclc | heather wakelee
-
2:44
disease-free survival in impower010 trial: adjuvant atezolizumab in nsclc
-
4:48
keynote-091 and impower010: adjuvant chemotherapy for nsclc
-
16:43
radiant and select: is adjuvant erlotinib effective in early-stage lung cancer?
-
3:17
impower010: os results of atezolizumab vs best supportive care in resected nsclc
-
4:45
gracecastuc-019_lung_case in point: recommendation for adjuvant chemotherapy for high risk tumors
-
22:32
gracecast-022_lung-cancer_cancer lifeline lecture part 2 adjuvant chemo
-
6:02
choices among immunotherapeutics may be the future of lung cancer care
-
4:50
impower010: adjuvant atezolizumab improves dfs in resected stage ii-iiia nsclc
-
7:45
onctalk 2021 - pdl1 and imfinzi/durvalumab
-
9:22
adjuvant immunotherapy: the imvigor trials - bladder cancer video library
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
4:17
fda approves atezolizumab as adjuvant treatment for non-small cell lung cancer
-
1:45
gracecastuc-076_lung_utility of molecular marker results in adjuvant setting for early stage nsclc
-
6:09
impower010: a phase 3 study of atezolizumab vs best supportive care after adjuvant chemotherapy ...